Cargando…
Electrotransfer of Plasmid DNA Encoding an Anti-Mouse Endoglin (CD105) shRNA to B16 Melanoma Tumors with Low and High Metastatic Potential Results in Pronounced Anti-Tumor Effects
Endoglin overexpression is associated with highly proliferative tumor endothelium and also with some tumors, including melanoma. Its targeting has anti-tumor effectiveness, which can also be obtained by RNA interference. The aim of our study was to explore the anti-tumor effectiveness of endoglin si...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4728450/ https://www.ncbi.nlm.nih.gov/pubmed/26712792 http://dx.doi.org/10.3390/cancers8010003 |
_version_ | 1782412112509796352 |
---|---|
author | Dolinsek, Tanja Sersa, Gregor Prosen, Lara Bosnjak, Masa Stimac, Monika Razborsek, Urska Cemazar, Maja |
author_facet | Dolinsek, Tanja Sersa, Gregor Prosen, Lara Bosnjak, Masa Stimac, Monika Razborsek, Urska Cemazar, Maja |
author_sort | Dolinsek, Tanja |
collection | PubMed |
description | Endoglin overexpression is associated with highly proliferative tumor endothelium and also with some tumors, including melanoma. Its targeting has anti-tumor effectiveness, which can also be obtained by RNA interference. The aim of our study was to explore the anti-tumor effectiveness of endoglin silencing by electrotransfer of plasmid DNA encoding short hairpin RNA against endoglin in two murine B16 melanoma variants with different metastatic potential on cells, spheroids and subcutaneous tumors in mice. The results demonstrate that endoglin silencing with gene electrotransfer reduces the proliferation, survival and migration of melanoma cells and also has anti-tumor effectiveness, as the therapy resulted in a high percentage of tumor cures (23% and 58% on B16F1 and B16F10 tumors, respectively). The effectiveness of the therapy correlated with endoglin expression in melanoma cells; in vitro the effects were more pronounced in B16F1 cells, which express more endoglin than B16F10. However, the opposite was observed in vivo in tumors, where there was a higher expression of endoglin and better anti-tumor effectiveness in the B16F10 tumor. In conclusion, targeting endoglin for the treatment of melanoma seems to be a concept worthy of further exploration due to the increased therapeutic effect of the therapy based on simultaneous vascular targeting and its direct effect on tumor cells. |
format | Online Article Text |
id | pubmed-4728450 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-47284502016-02-08 Electrotransfer of Plasmid DNA Encoding an Anti-Mouse Endoglin (CD105) shRNA to B16 Melanoma Tumors with Low and High Metastatic Potential Results in Pronounced Anti-Tumor Effects Dolinsek, Tanja Sersa, Gregor Prosen, Lara Bosnjak, Masa Stimac, Monika Razborsek, Urska Cemazar, Maja Cancers (Basel) Article Endoglin overexpression is associated with highly proliferative tumor endothelium and also with some tumors, including melanoma. Its targeting has anti-tumor effectiveness, which can also be obtained by RNA interference. The aim of our study was to explore the anti-tumor effectiveness of endoglin silencing by electrotransfer of plasmid DNA encoding short hairpin RNA against endoglin in two murine B16 melanoma variants with different metastatic potential on cells, spheroids and subcutaneous tumors in mice. The results demonstrate that endoglin silencing with gene electrotransfer reduces the proliferation, survival and migration of melanoma cells and also has anti-tumor effectiveness, as the therapy resulted in a high percentage of tumor cures (23% and 58% on B16F1 and B16F10 tumors, respectively). The effectiveness of the therapy correlated with endoglin expression in melanoma cells; in vitro the effects were more pronounced in B16F1 cells, which express more endoglin than B16F10. However, the opposite was observed in vivo in tumors, where there was a higher expression of endoglin and better anti-tumor effectiveness in the B16F10 tumor. In conclusion, targeting endoglin for the treatment of melanoma seems to be a concept worthy of further exploration due to the increased therapeutic effect of the therapy based on simultaneous vascular targeting and its direct effect on tumor cells. MDPI 2015-12-24 /pmc/articles/PMC4728450/ /pubmed/26712792 http://dx.doi.org/10.3390/cancers8010003 Text en © 2015 by the authors; licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons by Attribution (CC-BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Dolinsek, Tanja Sersa, Gregor Prosen, Lara Bosnjak, Masa Stimac, Monika Razborsek, Urska Cemazar, Maja Electrotransfer of Plasmid DNA Encoding an Anti-Mouse Endoglin (CD105) shRNA to B16 Melanoma Tumors with Low and High Metastatic Potential Results in Pronounced Anti-Tumor Effects |
title | Electrotransfer of Plasmid DNA Encoding an Anti-Mouse Endoglin (CD105) shRNA to B16 Melanoma Tumors with Low and High Metastatic Potential Results in Pronounced Anti-Tumor Effects |
title_full | Electrotransfer of Plasmid DNA Encoding an Anti-Mouse Endoglin (CD105) shRNA to B16 Melanoma Tumors with Low and High Metastatic Potential Results in Pronounced Anti-Tumor Effects |
title_fullStr | Electrotransfer of Plasmid DNA Encoding an Anti-Mouse Endoglin (CD105) shRNA to B16 Melanoma Tumors with Low and High Metastatic Potential Results in Pronounced Anti-Tumor Effects |
title_full_unstemmed | Electrotransfer of Plasmid DNA Encoding an Anti-Mouse Endoglin (CD105) shRNA to B16 Melanoma Tumors with Low and High Metastatic Potential Results in Pronounced Anti-Tumor Effects |
title_short | Electrotransfer of Plasmid DNA Encoding an Anti-Mouse Endoglin (CD105) shRNA to B16 Melanoma Tumors with Low and High Metastatic Potential Results in Pronounced Anti-Tumor Effects |
title_sort | electrotransfer of plasmid dna encoding an anti-mouse endoglin (cd105) shrna to b16 melanoma tumors with low and high metastatic potential results in pronounced anti-tumor effects |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4728450/ https://www.ncbi.nlm.nih.gov/pubmed/26712792 http://dx.doi.org/10.3390/cancers8010003 |
work_keys_str_mv | AT dolinsektanja electrotransferofplasmiddnaencodinganantimouseendoglincd105shrnatob16melanomatumorswithlowandhighmetastaticpotentialresultsinpronouncedantitumoreffects AT sersagregor electrotransferofplasmiddnaencodinganantimouseendoglincd105shrnatob16melanomatumorswithlowandhighmetastaticpotentialresultsinpronouncedantitumoreffects AT prosenlara electrotransferofplasmiddnaencodinganantimouseendoglincd105shrnatob16melanomatumorswithlowandhighmetastaticpotentialresultsinpronouncedantitumoreffects AT bosnjakmasa electrotransferofplasmiddnaencodinganantimouseendoglincd105shrnatob16melanomatumorswithlowandhighmetastaticpotentialresultsinpronouncedantitumoreffects AT stimacmonika electrotransferofplasmiddnaencodinganantimouseendoglincd105shrnatob16melanomatumorswithlowandhighmetastaticpotentialresultsinpronouncedantitumoreffects AT razborsekurska electrotransferofplasmiddnaencodinganantimouseendoglincd105shrnatob16melanomatumorswithlowandhighmetastaticpotentialresultsinpronouncedantitumoreffects AT cemazarmaja electrotransferofplasmiddnaencodinganantimouseendoglincd105shrnatob16melanomatumorswithlowandhighmetastaticpotentialresultsinpronouncedantitumoreffects |